FDA Inspection
Novo Nordisk Production Ireland LimitedNovo Nordisk Production Ireland Limited – FDA Inspection, Oct 28, 2022
Record Details
This FDA Inspection record concerns Novo Nordisk Production Ireland Limited, with an inspection on October 28, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 28, 2022
- Product Type
- Drugs
View Company Profile
ID · 42fff99a-e83b-468b-8703-2a066c7782e0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1202701
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novo Nordisk Production Ireland Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 5, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2019 | Not classified | Office of Inspections and Investigations | |
| January 25, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 7, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk Production Ireland Limited
- FDA Inspection 1205233 - 2023-04-05
- FDA Inspection 1096315 - 2019-06-21
- FDA Inspection 1043417 - 2018-01-25
- FDA Inspection 993675 - 2016-11-18
- FDA Inspection 902814 - 2014-11-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.